An Integrated Approach for Experimental Target Identification of Hypoxia-induced miR-210*
- Pasquale Fasanaro‡,
- Simona Greco‡,
- Maria Lorenzi§,
- Mario Pescatori¶,
- Maura Brioschi‖,
- Ritu Kulshreshtha**,1,
- Cristina Banfi‖,
- Andrew Stubbs¶,
- George A. Calin‡‡,
- Mircea Ivan§§,
- Maurizio C. Capogrossi¶¶ and
- Fabio Martelli¶¶,2
- From the ‡IRCCS-Policlinico San Donato, San Donato Milanese, 20097 Milan, Italy,
- the §Istituto Nazionale di Riposo e Cura per Anziani, 60121 Ancona, Italy,
- the ¶Erasmus Medical Centre, 3015 Rotterdam, The Netherlands,
- the ‖Centro Cardiologico Monzino-IRCCS, 20138 Milan, Italy,
- the **Tufts-New England Medical Center, Boston, Massachussetts 02111,
- the ‡‡Anderson Cancer Center, Houston, Texas 77030,
- §§Indiana University, Indianapolis, Indiana 46202, and
- the ¶¶Istituto Dermopatico dell'Immacolata-IRCCS, 00167 Rome, Italy
- ↵2 To whom correspondence should be addressed: Laboratorio Patologia Vascolare, Istituto Dermopatico dell'Immacolata-IRCCS, 00167 Rome, Italy. Tel.: 390666462431; Fax: 390666462430; E-mail: f.martelli{at}idi.it.
Abstract
miR-210 is a key player of cell response to hypoxia, modulating cell survival, VEGF-driven endothelial cell migration, and the ability of endothelial cells to form capillary-like structures. A crucial step in understanding microRNA (miRNA) function is the identification of their targets. However, only few miR-210 targets have been identified to date. Here, we describe an integrated strategy for large-scale identification of new miR-210 targets by combining transcriptomics and proteomics with bioinformatic approaches. To experimentally validate candidate targets, the RNA-induced silencing complex (RISC) loaded with miR-210 was purified by immunoprecipitation along with its mRNA targets. The complex was significantly enriched in mRNAs of 31 candidate targets, such as BDNF, GPD1L, ISCU, NCAM, and the non-coding RNA Xist. A subset of the newly identified targets was further confirmed by 3′-untranslated region (UTR) reporter assays, and hypoxia induced down-modulation of their expression was rescued blocking miR-210, providing support for the approach validity. In the case of 9 targets, such as PTPN1 and P4HB, miR-210 seed-pairing sequences localized in the coding sequence or in the 5′-UTR, in line with recent data extending miRNA targeting beyond the “classic” 3′-UTR recognition. Finally, Gene Ontology analysis of the targets highlights known miR-210 impact on cell cycle regulation and differentiation, and predicts a new role of this miRNA in RNA processing, DNA binding, development, membrane trafficking, and amino acid catabolism. Given the complexity of miRNA actions, we view such a multiprong approach as useful to adequately describe the multiple pathways regulated by miR-210 during physiopathological processes.
Footnotes
-
↵* This work was supported in part by Ministero della Salute Grants RF06-conv.29/07-1, RF07-conv-85.1, RBLA035a4X-001, RF05-conv.66-1, RF07-55.1, and RF07-strat.
-
↵
The on-line version of this article (available at http://www.jbc.org) contains supplemental Tables ST1–11, Figs. SF1–4, and “Materials.”
- Received August 6, 2009.
- Revision received October 2, 2009.
- © 2009 by The American Society for Biochemistry and Molecular Biology, Inc.











